The Global Fund to Fight AIDS, Tuberculosis and Malaria: Results and Innovation in Development Coope

1
The Global Fund to Fight AIDS, Tuberculosis and
MalariaResults and Innovation in Development
Cooperation for Health

• Silvia Ferazzi
• Manager, Donor Governments Team

Action for Global Health Conference Health
Warning Health MDGs and ODA Madrid, 26th and
27th May 2008
2
Contents
The Global Fund in the health and development
scene
Contribution of the Global Fund to aid
effectiveness
Funding scenarios and policy developments
3
The Global Fund in a historical context of
committment to health and development
4
The Global Fund is mandated to contribute to
achieving the MDGs

• MDG 1 Eradicate extreme poverty and hunger
• MDG 2 Achieve universal primary education
• MDG 3 Promote gender equality and empower women
• MDG 4 Reduce child mortality
• MDG 5 Improve maternal health
• MDG 6 Combat HIV/AIDS, malaria and other
  diseases
• MDG 7 Ensure environmental sustainability
• MDG 8 Build a partnership for development

Buenos Aires
5

A core set of principles inform the working
framework of the Global Fund

• Focus on financing

• Additionality

Spend it

• National ownership

• Participation

• Performance

• Independent review mechanism

BG/100407/1
6
The Global Fund is a key multilateral funder of
health for development

• 572 grants in 136 countries approved with a
  value of US10.7 billion

• 60 of Global Fund resources committed to AIDS
  15 to TB 25 to malaria

• Over 2/3 of international financing for
  tuberculosis and malaria 22 of the
  international commitment to AIDS

• 60 per cent of funding to sub-Saharan Africa

• 93 to support low-income and lower middle
  income countries

• 50/50 proportion of government and
  non-government implementers (principal recipients
  and sub-recipients)

7
European ODA is the core funding source of Global
Fund
Pledges and contributions 2002-2010 and beyond
USD 19.5 billion
8
The Global Fund in the health and development
scene
Contribution of the Global Fund to aid
effectiveness
Funding scenarios and policy developments
9
Indicators of grant performance show broad
coverage and acceleration of results
10
A number of implementing countries show early
signs of impact on the MDGs
11
The Global Fund invests in the harmonization and
alignment agenda
Paris Declaration on aid effectiveness

• Global Fund includes participation and
  harmonization concerns in its model
  multi-stakeholder Board and Country Coordinating
  Mechanisms representing donors, recipients, NGOs,
  private sector, civil society, people living with
  diseases
• Signatory of the Paris Declaration on aid
  effectiveness
• - Self-assesses against Paris principles (Accra
  process)
• - Delegated responsibility for global
  initiatives in measuring follow-up
• Actively involved in international harmonization
  efforts (H8, IHP)

National Strategy Financing (2009)
SE/290607/1
12
The Global Fund in the health and development
scene
Contribution of the Global Fund to aid
effectiveness
Funding scenarios and policy developments
13
The Global Fund is not contributing yet at full
potential to global resource needs
14
The gap between existing resources and funding
potential is still huge
4.5
4
3.5
Global Fund expected income
15
Sustaining demand requires mobilization of
partnerships and opens new funding windows

• Promote alliances and harmonization with
  partners for capacity building

• Respond rapidly and effectively to new threats

• Strengthen alignment with national processes and
  funding of national plans

• Widen window for health system support

• Reach out to less accessible areas and most
  vulnerable groups civil society and communities

16
Support to health systems 1. Funding components
with HS effects
17
Support to health systems 2. Providing relief
to health services
ACT treatment
ITN scale up
18
Support to health systems 3. Broadening
opportunities Round 8
Rationale HSS interventions can be funded when
they show clear outcome for the three diseases
How to include HSS interventions in a funding
proposal

• Health system component within one or more
  disease components, or

• Cross-cutting interventions through a separate
  section

19

HSS window to support gender mainstreaming

• Disaggregated data in the epidemiological
  background and in the indicators of performance

• Gap analysis that allows funding specific gender
  needs of beneficiaries (e.g. through integration
  of sexual and reproductive health)

19
20
HSS window to support community systems
Dual track financing Recommendation for
inclusion of both government and non-government
actors as Principal Recipients for Global Fund
financing

• Community systems strengthening
• Proposals have to include gap analysis
  highlighting how communities are involved in
  service delivery
• Funding window for community based
  organizations, including physical infrastructure,
  organizational needs and partnership
  opportunities

20